Introducing a new way to improve bioinformatics efficiency in your high-throughput NGS setting It’s exciting that advancements in high-throughput sequencing…
A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading…
Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…
QIAGEN Digital Insights Wednesday, December 5, 2018
HGMD® Professional version 2018.4 contains a total of 248,700 mutations entries—that’s 8,431 more mutation entries than the previous release! Unlike other…